Form 4 for ADPT Adaptive Biotechnologies Corp
Accepted 2025-03-06 00:00:00 ET · period of report 2025-03-04 · accession 0001062993-25-004815 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-06 | 2025-03-04 | ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | A - Grant | $0.00 | +110.0K | 437.4K | +34% | $0 |
| DM | 2025-03-06 | 2025-03-05 | ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | S - Sale | $6.98 | -44.7K | 392.7K | -10% | -$311.8K |
| D | 2025-03-06 | 2025-03-04 | ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | A - Grant | $0.00 | +165.0K | 165.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-04 | A | A | 109,973 | $0.00 | 437,388 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-05 | S | D | 41,600 | $6.98 | 395,788 | D | — | — | |
| 3 | Common | Common Stock | 2025-03-05 | S | D | 3,065 | $6.99 | 392,723 | D | — | — | |
| 4 | Derivative | Stock Option (right to buy) | 2025-03-04 | A | A | 165,027 | $0.00 | 165,027 | D | $8.12 · — to 2035-03-04 | 165,027 Common Stock | (F2) The options vest with respect to 1/4 of such shares on March 4, 2026, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. |